5-fluorouracil derivatives. XXII. Synthesis and antitumor activities of 1-carbamoyl-5-fluorouracils

Chemical and Pharmaceutical Bulletin

Volumn 45, Issue 8, 1997, Pages 1372-1375

  Ozaki, Shoichiro ^a   Kong, Xiangzheng ^a   Watanabe, Yutaka ^b   Hoshiko, Tomonori ^b   Koga, Toshikazu ^b   Ogasawara, Tomio ^b   Takizawa, Tsuneharu ^b   Fujisawa, Hiroshi ^b   Iigo, Masaaki ^c   Hoshi, Akio ^c  

^a SHANDONG UNIVERSITY   (China)

^b EHIME UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

1 (3 methylcyclohexyl) 5 fluorouracil; 1 (4 methoxycyclohexyl) 5 fluorouracil; 1 carbamoyl 5 fluorouracil; 5 fluorouracil; Antitumor agent

Indexed keywords

1 (3 METHYLCYCLOHEXYL) 5 FLUOROURACIL; 1 (4 METHOXYCYCLOHEXYL) 5 FLUOROURACIL; 5 FLUOROURACIL 1 CARBOXAMIDE DERIVATIVE; ANTINEOPLASTIC AGENT; CARMOFUR; FLUOROURACIL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; LEUKEMIA L 1210; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0030868669     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.45.1372     Document Type: Article

References (19)

1. Duschinski R., Pleven F., Heidelberger C., J. Am. Chem. Soc., 79, 4559 (1957).
2. Daher G. C., Harris B. E., Diasio R. B., Pharmac. Ther., 48, 189 (1990).
3. Hiller S. A., Zhuk S. A., Lidac M., Doc. Akad. Nauk SSSR, 176, 332 (1967).
4. Sakai T. T., Pogolloti A. L., Santi D. V., J. Heterocyclic. Chem., 5, 849 (1968).
5. Saita T., Kinoshita M., Imoto M., Bull. Chem. Soc. Jpn., 46, 2406 (1973).
6. Tada M., Chem. Lett., 1975, 129.
7. Ozaki S., Ike Y., Mizuno H., Ishikawa K., Mori H., Bull. Chem. Soc. Jpn., 50, 2406 (1977).
8. Ozaki S., Watanabe W., Hoshiko H., Ishikawa K., Mori H., Chem. Pharm. Bull., 32, 733 (1984).
9. Ozaki S., Watanabe Y., Hoshiko T., Nagase T., Ogasawara T., Furukawa H., Uemura A., Ishikawa K., Mori H., Hoshi A., Iigo M., Tokuzen R., Chem. Pharm. Bull., 34, 150 (1986).
10. Hoshiko T., Ozaki S., Watanabe Y., Ogasawara T., Yamauchi Y., Fujisawa K., Hoshi A., Iigo M., Chem. Pharm. Bull., 33, 2832 (1985).
11. Nagase T., Shiraishi K., Yamada Y., Ozaki S., Heterocycles, 27, 1155 (1988).
12. Ozaki S., Medicinal Research Reviews, 16, 51 (1996).
13. a) Hoshi A., Iigo M., Nakamura A., Yoshida M., Kuretani K., Gan, 67, 725 (1976);
14. b) Hoshi A., Iigo M., Nakamura A., Inomata M., Kuretani K., Chem. Pharm. Bull., 26, 161 (1978).
15. a) Koyama Y., Gan To Kagakuryoho, 7, 1181 (1980);
16. b) Nakanishi M., Tsutanishi Y., Nakamura T., Hashimoto I., Sawata Y., Kawai M., Okuno T., Fujisawa S., Taneda M., Yakuri To Chiryo, 8, 1211 (1980).
17. Ozaki S., Chem. Reviews, 72, 457 (1972).
18. Yamada S., Ninomiya K., Shioiri T., Tetrahedron Lett., 1973, 2343.
19. Noyce D. S., Dolby L. K., J. Org. Chem., 26, 1732 (1961).